Tissue Engineering for Meniscus Regeneration by Elizaveta Kon et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Tissue engineering for meniscus regeneration 429
Tissue engineering for meniscus regeneration
Elizaveta Kon, Giuseppe Filardo, Marco Delcogliano, Giuseppe Peretti, Alessandro Di 
Martino and Maurilio Marcacci
X 
 
Tissue engineering for meniscus regeneration 
 
Elizaveta Kon*, Giuseppe Filardo*, Marco Delcogliano**, Giuseppe Peretti°, 
Alessandro Di Martino* and Maurilio Marcacci* 
*IX Division, Biomechanics Lab, Rizzoli Orthopaedic Institute, Bologna, Italy 
°Orthopaedic Department, Ospedale San Raffaele,Università Vita Salute, 
 Milan, Italy 
**Orthopaedics and Traumatology Department, Ospedale San Carlo di Nancy, 
Rome, Italy 
 
1. Introduction 
Menisci represent fundamental structures for the maintenance of knee homeostasis, playing a 
key role in knee biomechanics. Lesions of the meniscus are frequently observed in orthopedic 
practice. Injury to the meniscus is one of the most common problems in the knee joint, with a 
mean annual incidence of 60 to 70 per 100 000 knee injuries  (Erkman et al. 1975; Hede et al 
1990; Neilson et al 1991; Renstrom P 1990; Weinand et al 2006). Injury or loss of meniscal tissue 
leads to pain, knee dysfunction and osteoarthritis at long term (Cook et al 2005; Wyland 2002). 
Studies have demonstrated that knee degeneration is inversely related to the amount of 
meniscal tissue resected (McDermott and Amis 2006; Rijk 2004). Unfortunately, their intrinsic 
regenerative potential is poor. Healing is usually limited to the vascularized areas in the outer 
one third of the meniscus (Arnoczky and Warren 1983; Miller 1994). When a lesion involves 
the avascular portion of the meniscus, the reparative process cannot occur, since it emanates 
from bleeding and subsequent inflammation. As a result, the standard biological healing 
process produces limited results. Thus, a large proportion of meniscal tears observed at 
arthroscopy remain irreparable, and partial, subtotal or even total meniscectomy is often 
necessary, regardless of the recognized consequence. Even after an only partial meniscectomy, 
knee mechanics are subject to dramatic changes, leading often to the development of early 
osteoarthritis. Therefore, menisci should be repaired whenever possible. 
In the last decades, tissue engineering approaches have been advocated to improve the 
reparative processes of joint tissues. The possibility to entirely reproduce the meniscus 
structure and function is highly attractive, and some new biomaterials have been studied 
and applied in preclinical and clinical studies. 
 
2. Preclinical studies 
In the last decade, replacement strategies have been applied to the menisci tissue in order to 
enhance their intrinsic reparative properties (Peretti et al. 1999; Peretti et al. 2004; Weinand 
et al. 2006) or even to replace them with an engineered tissue. Several materials have been 
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tested as partial meniscus substitutes in preclinical studies. Veth et al  (Veth et al. 1986) used 
carbon fiber for meniscus repair in dogs, with poor results. Small intestine submucosa (SIS) 
was successfully used to repair posterior vascular meniscal defects (Cook et al. 2006), but 
not for complete substitution. Total meniscus substitution remains difficult and has been 
poorly described in the literature. A polyvinyl alcohol-hydrogel meniscus in rabbits showed 
interesting results in terms of chondroprotection, but certain unresolved problems persisted: 
durability of the polymer, fixation method, complete tissue regeneration in a material that 
does not adhere to tissue (De Groot et al. 1997; Kobayashi et al.2003). Van Tienen et al (Van 
Tienen et al 2006) studied two different porous polyester urethane polymers as meniscus 
substitutes in dogs. Despite the promising results in tissue formation, one of the materials 
(aromatic 4,4,-diphenylmethanediisocynate) is thought to degrade into toxic products. Other 
polymer implants did not show to prevent cartilage degeneration or were not suitable as 
meniscal substitute because of poor tissue ingrowth related to polymer degradation rate and 
poor mechanical properties (Van Tienen et al. 2002; Van Tienen et al 2003). Tissue 
engineering has recently been proposed as a possible solution for meniscal regeneration. A 
few animal studies investigated the possibility of using cells in combination with different 
scaffold biomaterials for a partial or total meniscal substitution (Van Tienen et al. 2002; Van 
Tienen et al 2003; Van Tienen et al 2006; Weinand et al 2006; Chiari et al. 2006; Kon et al 
2008).  
Several polymers, both natural and synthetic, have been tested for engineering meniscal and 
cartilage tissue in vitro or in vivo. Among the synthetic scaffolds, favorable polymers are open 
lattice structures with large pores into which cartilage matrix is permitted to form and new 
synthetic hydrogels are also good candidate scaffolds for generating meniscal tissue. 
Collagen sponges have many desirable properties as a biological scaffold, including 
porosity, biodegradability, and biocompatibility. Multiple methods for preparing collagen 
and collagen-GAG scaffolds have been reported.  Generally, collagen scaffolds are made 
from animal tissues such as type I collagen from bovine tendon. It is also possible to 
chemically modify the biomechanical and biological properties of the collagen scaffolds to 
enhance certain characteristics that promote tissue formation (Speer et al. 1979). Open lattice 
collagen scaffolds, some of which also include glycosaminoglycans, have been synthesized 
and used for generating new matrix. Following the list of the potential biological scaffolds 
for meniscus repair, hyaluronan could play an important role. A resorbable biomaterial 
consisting of hyaluronic acid and polycaprolactone was also tested for total meniscal 
substitution (Kon et al; 2008). 
The other critical element for engineering meniscal tissue is finding the most suitable cell 
source. Various cell-sources have been evaluated in vitro to find the most suitable source for 
cell augmentation of tissue engineered meniscus. Meniscal cells can be isolated by enzymatic 
digestion of the tissue. Histological evidence suggests that the meniscal cells are capable of 
generating fibrocartilagenous tissue resembling meniscus. It is unlikely, however, that 
autologous meniscal fibrochondrocytes will be used to engineer one’s own meniscus because 
of the lack of expendable donor sites. It is conceivable that allogeneic meniscal cells could be 
used as an option for overcoming the donor site related problems. The central issue involving 
the use of allogeneic chondrocytes is their potential for eliciting an immune response once the 
extracellular matrix is removed and MHC antigens are exposed (Tiku et al. 1985). 
Different cell lines have been proposed as alternative solution for meniscal tissue 
engineering. Chondrocytes could be used to generate meniscal tissue or used to induce 
meniscal repair. Articular chondrocytes showed the highest tissue regeneration capacity, 
with cellular and matrix phenotypes similar to those of both the inner and outer meniscus 
regions (Ibarra et al. 2000; Marsano et al. 2007). 
Moreover, cartilage harvesting from a less loaded joint area would be less damaging to the 
knee biomechanics as compared to healthy meniscal tissue harvesting. Peretti et al (Peretti et 
al; 2004) have shown that articular chondrocytes seeded onto a devitalized allogenic 
meniscal slices or on a Vicryl mesh scaffold are capable of inducing a healing process in 
swine meniscus. Other alternative cartilage sources for obtaining cells include the cartilage 
portion of ribs or ear cartilage (Johonson et al 2004). MSCs are another valid candidate for 
meniscal bioengineering. Multiple experiments using human, chicken, dog, and rabbit 
MSCs have shown that, under controlled in vitro conditions, these cells can differentiate into 
bone, fat, tendon, muscle and cartilage-like tissues (Caplan et al. 2001; Pittenger et al. 1999; 
Conget et al. 1999). 
All these cell sources could be used to engineer reparative meniscal tissue. 
Walsh et al. (Wlash et al. 1999) used a collagenous sponge loaded with mesenchymal stem 
cells to treat a partial meniscus defect in rabbits. They reported that the presence of cells 
augmented the repair process but did not prevent knee degeneration. Martinek et al. 
(Martinek et al. 2006) documented better macroscopic and histological results in CMI 
implants seeded with meniscal fibrochondrocytes in comparison to cell-free implants in 
sheep. However, the tissue-engineered meniscus was biomechanically unstable and the 
implant size reduced during the three-month observation period. Therefore, the authors 
suggested that an improvement in scaffold and cell seeding procedure is required before 
human application.  
Ibarra et al. also reported on a pilot study in sheep where they used autologous meniscal 
fibrochondrocytes and PGA polymer (Ibarra et al. 2000). The authors report that the 
constructs produced a new tissue with fibroblasts and chondrocytes. The presence of 
collagen fibers was observed histologically and the cells produced proteoglycans. The 
number of animals was small, but the authors demonstrated proof-of-principle for the 
technique. Polyurethane was initially developed and tested in animal studies for total 
meniscal replacement but is now being assessed as a scaffold for partial meniscal 
replacement as an alternative for the CMI (Van Tienen et al. 2003). Brophy and colleagues 
(Brophy et al. 2008) showed in sheep cadavers that the contact pressures after partial 
meniscectomy and replacement with a polyurethane scaffold were less than the contact 
pressures after partial meniscectomy only. 
We have investigated the feasibility of using a new resorbable biomaterial consisting of 
hyaluronic acid and polycaprolactone for total meniscal substitution in a sheep model 
(Chiari et al. 2006; Kon et al. 2008). Twenty-four skeletally mature sheep were treated with 
total medial meniscus replacements while 2 meniscectomies served as empty controls. The 
animals were divided in two groups: cell free scaffold or scaffold seeded with autologous 
chondrocytes. Autologous chondrocytes were used as we have previously demonstrated 
that, both in vitro and following ectopic implantation, expanded articular chondrocytes 
were superior to meniscal cells, synovial or fat pad cells in their capacity to reach 
phenotypes typical of the inner and outer meniscus regions (Marsano et al. 2007). Two 
different surgical techniques were compared: in 12 animals the implant was sutured to the 
capsule and to the meniscal ligament and in the other 12 animals also a transtibial fixation of 
the horns was used. The animals were euthanized after 4 months. The specimens were 
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assessed by gross inspection and histology. All implants showed excellent capsular 
ingrowth at the periphery. Marcoscopically, no difference was observed between Cell 
Seeded and Cell Free group. Better implant appearance and integrity was observed in the 
group without trans-osseous horn fixation. Using the latter implantation technique, lower 
joint degeneration was observed in the cell-seeded group with respect to cell-free implants. 
The histological analysis indicated cellular infiltration and vascularisation throughout the 
implanted constructs. Cartilaginous tissue formation was significantly more frequent in the 
cell-seeded constructs. Our study supports the potential of the Hyaff/PCL scaffold for total 
meniscal substitution and seeding of the scaffolds with autologous chondrocytes provides 
some benefit in the extent of fibrocartilaginous tissue repair. 
  Fig. 1. Four month results after medial meniscus (left) replacement, (A) cell-seeded implants, 
(B) cell-free implants (left).  
 
3. Clinical studies 
Although the literature addresses merely the total replacement of the meniscus in animal 
studies, with or without cells, the current clinical studies only concern partial replacement of 
the resected meniscus with cell-free scaffolds. To the authors’ knowledge, no clinical studies 
have been published in which the meniscus was replaced by a bioengineered meniscus. 
Stone et al. (Stone et al. 1997) have developed a bioreadsorbable collagen matrix (CMI) 
which acts as a scaffold to restore the original medial meniscal. We studied (Zaffagnini et al. 
2007) and prospectively evaluated the results of CMI implantation at a follow-up from a 
minimum of 6 to a maximum of 8 years. Eight patients (mean age 25) were evaluated at a 
final observation point from 6 to 8 years after CMI implantation. Inclusion criteria were an 
irreparable meniscal tear or a previous meniscectomy involving the medial meniscus. There 
were no complications related to the device. All patients were able to return to daily 
activities without limitations 3 months after surgery. Both subjective CKRS score and 
objective IKDC score showed improvement in all cases except one patient with an ACL re-
injury. In two cases scores were slightly worse from 2 years after surgery to the final 
observation point. The other five cases obtained maximum score at final follow-up. In four 
cases the absence of pain remained until the final observation point, while in four cases a 
low entity of pain was described at long term follow-up. MRI showed in five cases mixoid 
degeneration signal, two had normal signal with reduced size, while one patient had no 
recognizable implant. Six patients had preserved cartilage and articular space, with no 
changes compared to pre-op control. Arthroscopic second look evaluation has been 
performed in three cases, revealing in two cases the presence of the implant, although with a 
reduced size compared to the original one, while in one case the CMI was almost 
disappeared. Our small series of eight patients prospectively followed from 6 to 8 years of 
follow-up has shown highly satisfactory results. Although the aspect of the implant was 
mostly abnormal, the implant may have helped reduce the deterioration of the knee joint at 
final observation time. 
Recently, a new polyurethane scaffold, presented by Brophy and colleagues (Brophy et al. 
2008), has been introduced in clinical practice. The polyurethanes are believed to have better 
material properties For fixation to the remaining native meniscus tissue and to resist the 
extreme forces within the knee joint. A prospective clinical trial, which is being performed at 
this moment, should reveal if this hypothesis would hold. The preliminary results seem 
promising. 
 
Fig. 2. New polyurethane scaffold. (Courtesy of Orteq Bioengineering) 
 
 Fig. 3. At 24 months increased tissue can be seen anterior to the residual rim of the native 
meniscus when compared to the month 12 findings. 
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4. Conclusion 
Subtotal or total meniscectomy is no longer considered a valid option for the treatment of 
meniscal tears, while preservation or regeneration of this tissue is now recommended, when 
possible, for the maintenance of a healthy knee. Menisci have poor intrinsic healing 
potential so that techniques based on fixation of the avascular regions of torn menisci often  
fail to allow for biological repair of the tissue. Until now, the properties of this tissue seemed 
hard to mimic. Tissue engineering for meniscal replacement represents an innovative and 
promising solution. Many materials have been proposed and tested in preclinical studies, 
but for the time being meniscus regeneration is still in its infancy, and further studies need 
to confirm the potential of the tissue engineering approach. 
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4. Conclusion 
Subtotal or total meniscectomy is no longer considered a valid option for the treatment of 
meniscal tears, while preservation or regeneration of this tissue is now recommended, when 
possible, for the maintenance of a healthy knee. Menisci have poor intrinsic healing 
potential so that techniques based on fixation of the avascular regions of torn menisci often  
fail to allow for biological repair of the tissue. Until now, the properties of this tissue seemed 
hard to mimic. Tissue engineering for meniscal replacement represents an innovative and 
promising solution. Many materials have been proposed and tested in preclinical studies, 
but for the time being meniscus regeneration is still in its infancy, and further studies need 
to confirm the potential of the tissue engineering approach. 
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